Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.
Press releases published on March 24, 2025

A' Prosumer Products and Workshop Equipment Design Award Announces Last Entry Period for 2025
Global Equipment Design Excellence Competition Extends Opportunity for Last Submissions Until March 30, 2025 COMO, CO, ITALY, March 24, 2025 /EINPresswire.com/ -- The A' Prosumer Products and Workshop Equipment Design Award, a highly prestigious …

SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025
DENVER, March 24, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced …

Octal’s Generative AI Chatbots Reshape Healthcare Delivery with Advanced Software
Octal IT Solution is transforming healthcare with its AI chatbots, improving patient care and operational efficiency. SARASOTA, FL, UNITED STATES, March 24, 2025 /EINPresswire.com/ -- The healthcare industry is rapidly embracing artificial …

Abitibi Metals Announces C$10 Million Bought Deal Financing
Not for distribution to U.S. news wire services or dissemination in the United States. LONDON, Ontario, March 24, 2025 (GLOBE NEWSWIRE) -- Abitibi Metals Corp. (CSE: AMQ) (OTCQB: AMQFF) (FSE: FW0) ("Abitibi" or the "Company") has announced today that it …

Linqura Launches AI-Powered Growth Engine Platform to Transform Business Insurance
Agentic-AI platform unlocks $80B in premium lift potential, empowering insurers and agents to work smarter, faster, and more profitably. HARTFORD, CT, UNITED STATES, March 24, 2025 /EINPresswire.com/ -- Linqura, the only AI-powered growth engine …

JSHASH Launches the Best Free Cloud Mining Option Regulated by the US: Helping Bitcoin and Dogecoin Enthusiasts Worldwide Earn a Passive Income Stream in 2025
Minneapolis, MN, March 24, 2025 (GLOBE NEWSWIRE) -- As cryptocurrency continues to gain traction in global financial markets, political leadership plays a crucial role in shaping industry policies. Former U.S. President Donald Trump has recently positioned …

Urgently Notified By Nasdaq Of Non-Compliance With Nasdaq’s Continued Listing Standards
VIENNA, Va., March 24, 2025 (GLOBE NEWSWIRE) -- Urgent.ly Inc. (Nasdaq: ULY) (“Urgently”), a U.S.-based leading provider of digital roadside and mobility assistance technology and services, announced today that The Nasdaq Stock Market LLC (“Nasdaq”) …

Louis Limited Expands Its Fintech and Education Services Globally
Louis Limited, a fintech education leader serving 6,000 Malaysian clients since 2019, is launching a global app integrating AI technology for financial learning. The platform will offer real-time market updates, achievement badges, mentorship, and …

Crown Castle Announces CEO Transition
Daniel Schlanger, Current Executive Vice President and CFO, Appointed Interim President and CEO Search Underway to Identify Successor CEO Reaffirms All Recently Announced Financial Guidance and Capital Allocation Policies Highly Confident in Value- …

Satellogic Reports 2024 Financial Results and Business Update
Revenue up 28% to $12.9 million in 2024 Redomicile to U.S. Nears Completion; Set to Accelerate Market Opportunities Completed $10 Million Private Placement Entered into $50 Million At-The-Market (ATM) Program NEW YORK, March 24, 2025 (GLOBE NEWSWIRE) -- …

Wrap Technologies, Inc. to Report Fourth Quarter 2024 and Full Year Financial Results on Monday, March 31, 2025 at 4:30 p.m. ET
MIAMI, March 24, 2025 (GLOBE NEWSWIRE) -- Wrap Technologies, Inc. (NASDAQ: WRAP) (“Wrap” or, the “Company”) today announced it will hold a conference call on Monday, March 31, 2025 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss its financial …

Serina Therapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights
HUNTSVILLE, March 24, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, today reported its financial results for …

Coherent Introduces Pluggable High Dynamic Range QSFP OTDR
SAXONBURG, PA, March 24, 2025 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, announces its latest advancement in fiber network diagnostics: a high-performance embedded Optical Time Domain Reflectometer (eOTDR) in a QSFP …

Enerpac Tool Group Reports Second Quarter Fiscal 2025 Results
Second Quarter of Fiscal 2025 Continuing Operations Highlights* Net sales were $146 million, a 5.1% increase compared to the prior year, with a 5.0% increase in organic sales.1 Operating profit margin was 21.2% and adjusted operating profit margin was 21. …

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
BDC-4182 on track to start a clinical trial in gastric cancer in second quarter 2025 BDC-3042 Phase 1 clinical trial fully enrolled the highest dose cohort with no dose-limiting toxicities (DLTs), results will be reported in second quarter 2025 Cash …

RedCloud Holdings Announces Closing of $20 Million Initial Public Offering
LONDON, March 24, 2025 (GLOBE NEWSWIRE) -- RedCloud Holdings plc (“RedCloud” or the “Company”), today announced the closing of its initial public offering of 4,444,445 of its ordinary shares at a public offering price of $4.50 per share (the “Offering”). …

Foresight Announces Fourth Quarter and Full Year 2024 Financial Results
NESS ZIONA, Israel, March 24, 2025 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd., (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in 3D perception systems, today reported financial results for the fourth quarter and full year …

Artiva Biotherapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights
Initial data for AlloNK® from autoimmune program expected H1 2025 Updated clinical data from Phase 1/2 trial exploring AlloNK + rituximab in NHL showing continued durability of response to be presented at a medical conference in 2025 Strengthened key …

NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy
First-in-human studies anticipated to begin in 2026 Engaged a top tier U.S. based contract manufacturer to ensure the highest standards of quality Currently in the advanced stages of formulation development for subcutaneous injection, with plans for an …

AEON Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
– Initiated analytical studies in Q4 2024 to prepare for a potential Biosimilar Biological Product Development (“BPD”) Type 2a meeting with the FDA in the second half of 2025 – – Pursuing a 351(k) regulatory pathway for ABP-450, which offers potential …